Baseline demographics and clinical characteristics of subjects enrolled in the phase 3 AURORA study of cenicriviroc for the treatment of liver fibrosis associated with non-alcoholic steatohepatitis

被引：0

作者：

Alkhouri, Naim ^{[1
]}

Wong, Vincent Wai-Sun ^{[2
]}

Jablkowski, Maciej ^{[3
]}

de Guevara, Alma Laura Ladron ^{[4
]}

Sheikh, Muhammad ^{[5
]}

Hodge, Alex ^{[6
]}

Elkhashab, Magdy ^{[7
]}

Strasser, Simone ^{[8
]}

Park, Grace S. ^{[9
]}

Landgren, Henrik ^{[10
]}

Tan, Bill ^{[11
]}

Massetto, Benedetta ^{[11
]}

Pecoraro, Maria Lucia ^{[11
]}

Seyedkazemi, Star ^{[11
]}

Martins, Eduardo Bruno ^{[11
]}

Fischer, Laurent ^{[11
]}

Abdelmalek, Manal ^{[12
]}

Tetri, Brent ^{[13
]}

Anstee, Quentin ^{[14
]}

机构：

[1] Univ Texas Hlth San Antonio, Texas Liver Inst, San Antonio, TX USA

[2] Chinese Univ Hong Kong, Hong Kong, Peoples R China

[3] Med Univ Lodz, Lodzkie, Poland

[4] Hosp Angeles Clin Londres, Mexico City, DF, Mexico

[5] Fresno Clin Res Ctr, Fresno, CA USA

[6] Monash Univ, Monash Med Ctr, Melbourne, Vic, Australia

[7] Toronto Liver Ctr, Toronto, ON, Canada

[8] Univ Sydney, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia

[9] Allergan PLC, Irvine, CA USA

[10] Allergan PLC, Marlow, Bucks, England

[11] Allergan PLC, San Francisco, CA USA

[12] Duke Univ, Durham, NC USA

[13] St Louis Univ, St Louis, MO 63103 USA

[14] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England

来源：

JOURNAL OF HEPATOLOGY | 2020年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI214

引用

页码：S508 / S508

页数：1

共 50 条

[31] Treatment of a non-alcoholic steatohepatitis cirrhotic patients with resmetirom: baseline characteristics and effects on safety, biomarkers and imaging
Harrison, Stephen
Alkhouri, Naim
Taub, Rebecca
Abdelmalek, Manal
Neff, Guy
JOURNAL OF HEPATOLOGY, 2021, 75 : S614 - S615
[32] Pro-C3 in combination with clinical parameters is associated with severity of histological features of non-alcoholic steatohepatitis and fibrosis
Leeming, Diana J.
Nielsen, Mette J.
Goodman, Zachary D.
Friedman, Scott L.
Lefebvre, Eric
Seyedka-Zemi, Star
Wiens, Brian
Fischer, Laurent
Karsdal, Morten A.
Sanyal, Arun J.
Ratziu, Vlad
HEPATOLOGY, 2017, 66 : 1107A - 1108A
[33] Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis
Francque, Sven M.
Hodge, Alexander
Boursier, Jerome
Younes, Ziad H.
Rodriguez-Araujo, Gerardo
Park, Grace S.
Alkhouri, Naim
Abdelmalek, Manal F.
HEPATOLOGY COMMUNICATIONS, 2024, 8 (02)
[34] SERUM DES-ACYLGHRELIN CONCENTRATION IS ASSOCIATED WITH HISTOLOGIC NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Estep, M.
Vernon, G.
Wang, L.
Stepanova, M.
Younoszai, A.
Elariny, H.
Goodman, Z.
Chandhoke, V.
Baranova, A.
Younossi, Z.
JOURNAL OF HEPATOLOGY, 2011, 54 : S350 - S351
[35] Reversibility of non-alcoholic steatohepatitis, and associated fibrosis, with aerobic exercise: An index case study.
Sparrow, CL
McMurray, RG
Gottfried, M
Swaim, MW
HEPATOLOGY, 2000, 32 (04) : 531A - 531A
[36] Incidence and risk of dyslipidemia and hyperglycemia in a phase 3 study of obeticholic acid for the treatment of non-alcoholic steatohepatitis
Abdelmalek, Manal
Capozza, Thomas
Davis, Pamela
Randhawa, Amarita
Sawhney, Sangeeta
JOURNAL OF HEPATOLOGY, 2023, 78 : S809 - S810
[37] A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis
Schwimmer, JB
Middleton, MS
Deutsch, R
Lavine, JE
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (07) : 871 - 879
[38] Serum soluble CD163 is associated with steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
Feeney, Eoin R.
Mueller, Jessica L.
Malecki, Kyle
King, Lindsay Y.
Misdraji, Joseph
Corey, Kathleen E.
Chung, Raymond T.
HEPATOLOGY, 2014, 60 : 602A - 602A
[39] Clinical and anthropometric characteristics of non-obese non-alcoholic fatty liver disease subjects in Japan
Shida, Takashi
Oshida, Natsumi
Suzuki, Hideo
Okada, Kosuke
Watahiki, Takahisa
Oh, Sechang
Kim, Taeho
Isobe, Tomonori
Okamoto, Yoshikazu
Ariizumi, Shun-ichi
Yamamoto, Masakazu
Shoda, Junichi
HEPATOLOGY RESEARCH, 2020, 50 (09) : 1032 - 1046
[40] Liver fibrosis is associated with cardiovascular disease burden amongst patients with non-alcoholic steatohepatitis: the unCoVer-NASH longitudinal cohort study
Corey, Kathleen
Mehta, Anurag
Mangla, Kamal Kant
Chandramouli, Abhishek Shankar
Patel, Ahsan Shoeb
Varma, Sharat
Bugianesi, Elisabetta
JOURNAL OF HEPATOLOGY, 2023, 78 : S620 - S620

← 1 2 3 4 5 →